Hyderabad: Vaccine maker Bharat Biotech invested Rs 1,500 crore in setting up what is touted as one of the world's largest ...

A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC, which has been approved for inclusion into India’s Covid-19 immunisation programme, will cost Rs 800 each plus 5 percent Goods ...

Hyderabad-based Bharat Biotech Ltd announced the launch of its oral cholera vaccine (OCV) Hillchol. This vaccine was ...

HYDERABAD: Hyderabad-based vaccine manufacturer Bharat Biotech International Limited (BBIL) on Tuesday announced the launch ...

When the COVID-19 pandemic hit in March 2020, it disrupted not only global health systems but also the way vaccine ...

India's drug regulator has approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use ... 印度本土生产的Covishield，印度Bharat Biotech研发的新冠疫苗Covaxin ...

Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar, ...

Singapore President visits Bharat Biotech's vaccine facility in Bhubaneswar, producing oral cholera and malaria vaccines for ...

Save your favourite. The recent studies highlight notable adverse events globally caused by COVID-19 vaccines, regardless of the technology and manufacturer. Bharat Biotech has emphasised the need ...

None of the Covid vaccines originally approved for emergency use completed trial results. Supreme Court should therefore ask ...

Showcasing Odishas potential for growth and development, President of Singapore Tharman Shanmugaratnam on Saturday ...

Hyderabad: The Indian National Science Academy (INSA) conferred its prestigious India fellowship for 2025 upon Dr Krishna Ella, co-founder and executive chairman of Bharat Biotech, which developed ...